Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 3/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15787310 | 0.91 | MAOA (0.48) | TAAR1CYP1A2CYP2A6HTR2AMAOA | |
| SCHEMBL17277597 | 0.89 | MAOA (0.43) | TAAR1CYP1A2CYP2A6HTR2AMAOA | |
| SCHEMBL537203 | 0.89 | TAAR1 (0.60) | TAAR1CYP1A2CYP2A6HTR2AHTR2C | |
| SCHEMBL12062435 | 0.88 | MAOA (0.42) | TAAR1CYP1A2CYP2A6HTR2AMAOA | |
| SCHEMBL17277406 | 0.88 | HTR2A (0.42) | TAAR1HTR2AMAOAHRH1 | |
| SCHEMBL17277615 | 0.86 | MAOA (0.41) | TAAR1CYP1A2CYP2A6MAOAHRH1 | |
| SCHEMBL17277470 | 0.86 | MAOA (0.41) | TAAR1CYP1A2CYP2A6MAOAHRH1 | |
| SCHEMBL4213627 | 0.84 | TAAR1 (0.45) | TAAR1CYP1A2CYP2A6HTR2AMAOA | |
| SCHEMBL3849051 | 0.84 | TAAR1 (0.60) | TAAR1CYP1A2CYP2A6HTR2AHTR2C | |
| SCHEMBL7436821 | 0.83 | MAOA (0.59) | MAOAHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9193731-B2 | Antimicrobial compounds and methods of making and using the same | MELINTA THERAPEUTICS, INC. (US) | 2015-11-24 | — | — | US | disclosed |